User:The Anome/Cancer dictionary test article list

This is a list of potential oncology articles generated by my Cancer Dictionary post-processor.

Now with all-uppercase codenames removed.

Low-hanging fruit
Autologous tumor cell - Brain stem tumor - Treosulfan -

Full list
Accelerated phase chronic myelogenous leukemia -- Actinex -- Acupuncture point injection -- Acute myeloblastic leukemia -- Adenosquamous carcinoma -- Adnexal mass -- Adriamycin PFS -- Adriamycin RDF -- Aggressive lymphoma -- AJCC staging system -- Allergic response -- Allogeneic bone marrow transplantation -- Allogeneic stem cell transplantation -- Allovectin-7 -- Aloe-emodin -- ALVAC-CEA vaccine -- Alzheimer dementia -- Amelanotic melanoma -- Amevive -- Aminoglycoside antibiotic -- Amonafide -- Amoxicillin-clavulanate potassium -- Amplimexon -- Amrubicin -- Androblastoma -- Anetholtrithione -- Angiozyme -- Animal study -- Annamycin -- Anterior mediastinotomy -- Anterior urethral cancer -- Anti-CD19 immunotoxin -- Anti-CD22 immunotoxin -- Anti-CD22 immunotoxin CAT-8015 -- Anti-EpCAM-Pseudomonas-exotoxin fusion protein -- Anti-idiotype vaccine -- Anti-IL-6 chimeric monoclonal antibody -- Anti-mesothelin monoclonal antibody MORAb-009 -- Anti-TGF-beta monoclonal antibody GC1008 -- Antiestrogen -- Antifolate -- Antigen-presenting cell vaccine -- Antiglobulin test -- Antimicrotubule agent -- Antimitotic agent -- Antineoplastic antibiotic -- Antiprogestin -- Antithymocyte globulin -- Antitumor antibiotic -- APC vaccine -- Arctigenin -- Arctiin -- Arginine butyrate -- Aromatherapy massage -- Atamestane -- Atiprimod -- Atrasentan -- Atypical hyperplasia -- Augmerosen -- Aurimmune -- Aurora kinase inhibitor AT9283 -- Autoclave-resistant factor -- Autologous bone marrow transplantation -- Autologous stem cell transplantation -- Autologous tumor cell -- Avita -- Axillary lymph node -- Axitinib -- Azaspirane -- Azoxymethane -- B-cell acute lymphoblastic leukemia -- B-cell acute lymphocytic leukemia -- B3 antigen -- B43-PAP immunotoxin -- Barium solution -- Batracylin -- BCG solution -- Bcl-2 antisense oligodeoxynucleotide G3139 -- Beclin 1 -- Bench-to-bedside -- Bendamustine -- Benign breast disease -- Benign proliferative breast disease -- Beriplast P -- Beta alethine -- Beta hemolytic streptococcus group B -- Bexxar regimen -- Biafine cream -- Binding agent -- Biochemical recurrence -- Biochemical relapse -- Biologic agent -- Biological drug -- Biological profile -- Biomed 101 -- Biorepository -- Bispecific monoclonal antibody -- BL22 immunotoxin -- Blastic phase chronic myelogenous leukemia -- Blinded study -- Blood chemistry study -- Bolus infusion -- Bone mass -- Bone-seeking radioisotope -- Brachial plexopathy -- BRAF gene -- Brain stem glioma -- Brain stem tumor -- Breast duct endoscopy -- Brief Pain Inventory -- Brostallicin -- Broxuridine -- Bryostatin 1 -- Bulk-forming agent -- Burkitt leukemia -- Buthionine sulfoximine -- C-erbB-2 -- C-kit receptor -- CA 19-9 assay -- Calendula ointment -- Cancell -- Cancer of the adrenal cortex -- Cancer of unknown primary origin -- Candidosis -- Cantron -- Carbon-11 acetate -- Carboxypeptidase-G2 -- Carcinosarcoma -- Carcinosis -- Carina tracheae -- CBR96-doxorubicin immunoconjugate -- CC49-streptavidin -- CD34 antigen -- CD40-ligand -- CDK inhibitor AT7519M -- CEA assay -- Cellular adoptive immunotherapy -- Central venous access catheter -- CEP-2563 dihydrochloride -- Cerebellar hemangioblastoma -- Cerebrospinal fluid diversion -- Cervical squamous intraepithelial neoplasia 1 -- Cervical squamous intraepithelial neoplasia 2 -- Charged-particle radiation therapy -- Chemoembolization -- Chemoprotective -- Chemosensitivity assay -- Chemosensitizer -- Child-life worker -- Cholangiosarcoma -- Chorioadenoma destruens -- Chorioblastoma -- Chorioepithelioma -- Chorionic carcinoma -- Choroid plexus tumor -- Chronic eosinophilic leukemia -- Chronic granulocytic leukemia -- Chronic idiopathic myelofibrosis -- Chronic phase chronic myelogenous leukemia -- Citric acid/potassium-sodium citrate -- Claus model -- Clear cell -- Clear cell adenocarcinoma -- Clear cell sarcoma of the kidney -- Clinical researcher -- Clolar -- Co-culture -- Coactivated T cell -- Collagen disease -- Colloidal gold-bound tumor necrosis factor -- Coloanal anastomosis -- Coloanal pull-through -- Combretastatin A4 phosphate -- Comedo carcinoma -- Compound nevus -- Compression pump -- Computed tomography colography -- Computerized axial tomography scan -- Concurrent therapy -- Congenital mesoblastic nephroma -- Consecutive case series -- Consensus Development Program -- Consolidation therapy -- Constitutional acupuncture -- Continent reservoir -- Contrast material -- Controlled clinical trial -- Controlled low-voltage electrical stimulation -- Conventional therapy -- Conventional treatment -- Coomb's test -- Corynebacterium granulosum -- Coumestrol -- CpG 7909 -- Crocinic Acid -- Cultured cell -- Cyanogenic glucoside -- Cytochlor -- Cytochrome P450 enzyme system -- Dacogen -- Dark-field microscope -- Dendritic cell vaccine -- Deslorelin -- Desmoplastic melanoma -- Dextroamphetamine-amphetamine -- DHA-paclitaxel -- Diagnostic procedure -- Diagnostic trial -- DIEP flap -- Dietary protocol -- Diffuse hyperplastic perilobar nephroblastomatosis -- Digital mammography -- Dilator -- Dimesna -- Diphosphonate -- DNA gene-expression microarray -- Dose-dense chemotherapy -- Double-blinded -- Double-contrast barium enema -- Dox-SL -- Doxercalciferol -- Doxorubicin hydrochloride liposome -- DT388IL3 fusion protein -- Ductal lavage -- Dukes classification -- Early menopause -- Early-stage cancer -- Ecteinascidin 743 -- Ectomesenchymoma -- Edotecarin -- Efaproxiral -- EGb761 -- Electrodiathermy -- Electrofulguration -- Ellence -- Embryoma -- Embryonal tumor -- Endocervical curettage -- Endocrine pancreas cell -- Endosonography -- Endothelin-1 protein receptor antagonist -- English chamomile -- Enterostomal therapist -- Enzastaurin -- Enzastaurin hydrochloride -- Ependymal tumor -- Epoetin beta -- Epothilone B -- Epothilone D -- Epothilone ZK219477 -- Erb-38 immunotoxin -- Erythrodysplasia -- Erythroid dysplasia -- Esomeprazole magnesium -- Esophageal stent -- Esophagram -- Esterified estrogen -- Estrogen receptor test -- Etanidazole -- Evacet -- Ewing family of tumors -- Excisional biopsy -- Excisional skin surgery -- Exjade -- Exocrine cancer -- Exocrine pancreas cell -- Experimental drug -- Extracorporeal photopheresis -- Extracranial germ cell tumor -- Extragonadal germ cell tumor -- Extrahepatic bile duct cancer -- Falimarev -- Familial dysplastic nevi -- Fast-neutron beam radiation -- Fatty-replaced breast tissue -- FdCyd -- Febrile neutropenia -- Ferumoxtran-10 -- Ferumoxytol -- Fibrocystic breast changes -- Filgrastim-SD/01 -- Flavopiridol -- Flt3L -- Fluorine F 18 EF5 -- Fluorine F 18 FEQA -- Fluorothymidine F 18 -- Folate antagonist -- Follicular large cell lymphoma -- Forodesine -- Forodesine hydrochloride -- Frankincense tree -- Ftorafur -- Fulguration -- Functioning tumor -- Fungating lesion -- Gadolinium texaphyrin -- Gail model -- Gallium nitrate -- Gamma irradiation -- Garden heliotrope -- Garden valerian -- Gastric atrophy -- Gd-DTPA -- Gelclair -- Genasense -- Gene expression profiling -- Genetic marker of susceptibility -- Gerota's capsule -- Giant cell fibroblastoma -- Gimatecan -- Gliadel Wafer -- Glial tumor -- Gliosarcoma -- Glycinamide ribonucleotide formyltransferase inhibitor -- GM2-KLH vaccine -- Gp209-2M -- Gp96 heat shock protein-peptide complex vaccine -- Gp96 HSP-peptide complex -- Grade 3 follicular lymphoma -- Grade IV astrocytoma -- Green tea extract -- Greene Menopause Index -- Halofuginone hydrobromide -- Happy major -- Helical computed tomography -- Hemagglutinin-neuraminidase -- Hematologic cancer -- Hematopoietic growth factor -- Hematoporphyrin derivative -- Hemihypertrophy -- Hepatic arterial infusion -- Hepatic arterial occlusion -- Hepatic veno-occlusive disease -- Hexyl 5-aminolevulinate -- High-dose-rate remote brachytherapy -- High-dose-rate remote radiation therapy -- High-energy photon therapy -- High-grade lymphoma -- Histamine dihydrochloride -- Historic cohort study -- HIV antibody -- Holmium Ho 166 DOTMP -- Holy thistle -- Hormone receptor test -- Host cell -- Hu3S193 -- Huang Lian -- HuC242-DM4 -- HuHMFG1 -- HuLuc63 -- Human T-cell leukemia virus type 1 -- Human T-cell lymphotropic virus type 1 -- HuMax-CD20 -- Hydrazine sulfate -- Hyperthermia therapy -- Hyperthermic perfusion -- Idiopathic pneumonia syndrome -- Idoxifene -- IgG-RFT5-dgA -- IH636 grape seed extract -- Imaging procedure -- Imexon -- Immature teratoma -- Immune adjuvant -- Immune complex hemolytic anemia -- Immunohemolytic anemia -- Immunological adjuvant -- Implant radiation therapy -- Implantable pump -- Incisional biopsy -- Incomplete Freund's adjuvant -- Indian valerian -- Indium In 111 ibritumomab tiuxetan -- Indolent lymphoma -- Infrared coagulation -- Innohep -- Intensification therapy -- Interleukin-13 PE38QQR immunotoxin -- Interleukin-4 PE38KDEL cytotoxin -- Interleukin-4 PE38KDEL immunotoxin -- Intermediate-grade lymphoma -- Internal examination -- Internal radiation therapy -- Interstitial radiation therapy -- Intracavitary radiation therapy -- Intraductal carcinoma -- Intraductal papilloma -- Intrahepatic bile duct -- Intraluminal intubation and dilation -- Intraperitoneal infusion -- Invasive hydatidiform mole -- Inverted papilloma -- Iodine I 131 monoclonal antibody BC8 -- Iodine I 131 tositumomab -- Iododoxorubicin -- Iseganan hydrochloride -- Isolated hepatic perfusion -- Isolated lung perfusion -- Ispinesib -- Ixempra -- J-pouch coloanal anastomosis -- Javlor -- Jim’s Juice -- Johimbe -- Junctional nevus -- Kahler disease -- Kaposi sarcoma-associated herpesvirus -- Karenitecin -- Kepivance -- Kidney function test -- Korean acupuncture -- L-3,5,5’-tetraiodothyronine -- L-norgestrel -- L-threo-dihydrosphingosine -- Laboratory test -- Lapatinib ditosylate -- Large granular lymphocyte -- Late-stage cancer -- Legal aid organization -- Leptomeningeal cancer -- Leridistim -- Lerisetron -- Levels of evidence -- Lignano -- Limb perfusion -- LipoDox -- Liposomal SN-38 -- Liquid-based Pap test -- LMB-1 immunotoxin -- LMB-2 immunotoxin -- LMB-7 immunotoxin -- LMB-9 immunotoxin -- Lobradimil -- Lofibra -- Lometrexol -- Low-grade lymphoma -- Lutetium texaphyrin -- LY353381 hydrochloride -- Lymph node dissection -- Lymphatic basin -- Magnetic resonance perfusion imaging -- Magnetic resonance spectroscopic imaging -- Magnetic-targeted carrier -- Mainstream medicine -- Malignant ascites -- Malignant ectomesenchymoma -- Malignant fibrous cytoma -- Malignant meningioma -- Malignant mesothelioma -- Malignant pleural effusion -- Mammotome -- Maribavir -- MART-1 antigen -- Mature teratoma -- Maytansinoid DM4-conjugated humanized monoclonal antibody huC242 -- Measurable disease -- Medial supraclavicular lymph node -- Mediastinoscope -- Medical oncologist -- Medullary breast carcinoma -- Melan-A protein -- Melanocortin 1 receptor -- Melanoma vaccine -- Melanotropin receptor -- Mesonephroma -- Metaplastic carcinoma -- Methoxypolyethylene glycol epoetin beta -- Methyl-5-aminolevulinate -- Mexican valerian -- Micromolar -- Microstaging -- Microwave acupuncture -- Microwave therapy -- Microwave thermotherapy -- Midostaurin -- Mind/body exercise -- Mindfulness relaxation -- Miraluma test -- Mistletoe lectin -- Mithracin -- Molecular pathway -- Molecular risk assessment -- Montanide ISA-51 -- MORAb-009 -- Motexafin lutetium -- Mucin/peptide -- Mucinous carcinoma -- MuJ591 -- Mullerian tumor -- Multicenter study -- Multidisciplinary opinion -- Multiple endocrine neoplasia type 1 syndrome -- Mustargen -- Myeloablation -- Myelomatosis -- Myelosclerosis with myeloid metaplasia -- Mylosar -- N-acetyl-L-cysteine -- N-acetyldinaline -- N-benzoyl-staurosporine -- N-butyl-N-(4-hydroxybutyl) nitrosamine -- Nanoparticle paclitaxel -- Nasoscope -- Natural history study -- NCI clinical trials cooperative group -- Needle-localized biopsy -- Negative axillary lymph node -- Negative test result -- Nephrotomogram -- Nerve-sparing surgery -- Neuro-oncologist -- Neuroectodermal tumor -- Neuroradiologist -- Nicotine inhaler -- Nicotine lozenge -- Nicotine nasal spray -- Nimustine -- Nitric oxide-releasing acetylsalicylic acid derivative -- Nodular lymphocyte-predominant Hodgkin lymphoma -- Nodular parenchyma -- Nolatrexed -- Nonconsecutive case series -- Nonfunctioning tumor -- Nonmalignant hematologic disorder -- Nonopioid -- Nonprescription -- Nonrandomized clinical trial -- Nonspecific immune cell -- Nonsteroidal aromatase inhibitor -- NR-LU-10 antigen -- Nuclear medicine scan -- O(6)-benzylguanine -- Objective response -- Oblimersen -- Octreotide scan -- Olfactory transduction -- Oligodendroglial tumor -- Oligofructose-enriched inulin -- Oltipraz -- Ommaya reservoir -- Oncaspar -- Oncology pharmacy specialist -- Oncophage -- Ontak -- Open biopsy -- Open label study -- Osteogenic sarcoma -- OvaRex -- Ovarian borderline malignant tumor -- Ovarian low malignant potential tumor -- Overgrowth syndrome -- Oxygen saturation test -- Pacific valerian -- Paclitaxel albumin-stabilized nanoparticle formulation -- Paclitaxel liposome -- Paclitaxel poliglumex -- Paclitaxel polyglutamate -- Paget disease of the nipple -- Palmar-plantar erythrodysesthesia -- Palpable disease -- Pancreatic endocrine cancer -- Pancreatic enzyme -- Papillary tumor -- Parathyrin -- Parathyroid cancer -- Paricalcitol -- Partial remission -- Partial response -- Paterson-Kelly syndrome -- Pathologic fracture -- Pathological staging -- Pazopanib hydrochloride -- Pediatric hematologist -- Pediatric nurse specialist -- Peer-reviewed scientific journal -- PEG-asparaginase -- PEG-interferon alfa-2a -- PEG-interferon alfa-2b -- PEG-Intron -- PEG-rhMGDF -- Pegylated arginine deiminase -- Peldesine -- Penclomedine -- Pentetic acid calcium -- Peptide 946 -- Percutaneous transhepatic biliary drainage -- Perfusion magnetic resonance imaging -- Periampullary cancer -- Perifosine -- Perillyl alcohol -- Peripheral blood lymphocyte therapy -- Peripheral primitive neuroectodermal tumor -- Peripheral stem cell support -- Peripheral stem cell transplantation -- Peripheral venous catheter -- Peritoneal fluid -- Peritoneal infusion -- Peritoneal perfusion -- Pet-facilitated therapy -- Phase I detoxification -- Phase I/II trial -- Phase II detoxification -- Phase II trial -- Phase II/III trial -- Phase III trial -- Phenoxodiol -- Phenylbutyrate -- Phosphatidylinositol-3 kinase -- Phospholipid complex -- Photofrin -- Photon-beam radiation -- Photosensitizing agent -- Physical medicine specialist -- Pineal organ -- Pineal region tumor -- Pineoblastoma -- Pineocytoma -- Pirfenidone -- Piritrexim -- Plaque radiotherapy -- Plasma cell myeloma -- Plasma cell tumor -- Plexopathy -- Pneumatic larynx -- Polifeprosan 20 carmustine implant -- Poly-ICLC -- Polyethylene glycosylated recombinant human megakaryocyte growth and development factor -- Polyglutamate camptothecin -- Polyphenon E -- Polyvinylpyrrolidone-sodium hyaluronate gel -- Population study -- Porfiromycin -- Positive axillary lymph node -- Positive test result -- Posterior urethral cancer -- Precancerous dermatitis -- Precancerous dermatosis -- Precursor B-lymphoblastic leukemia -- Precursor T-lymphoblastic leukemia -- Precursor T-lymphoblastic lymphoma -- Predictive factor -- Premycotic phase -- Primary care doctor -- Primary myelofibrosis -- Primary ovarian insufficiency -- Prinomastat -- Progesterone receptor test -- Prognostic factor -- Proliferative index -- ProMune -- Prospective cohort study -- Prost 30 -- Prostate-specific antigen test -- Prosthodontist -- Protocel -- Proton beam radiation therapy -- Proton magnetic resonance spectroscopic imaging -- Proxinium -- PSA bounce -- PSA failure -- Pulmonary sulcus tumor -- Pyrazine diazohydroxide -- Pyrazoloacridine -- Pyroxamide -- R-tPA -- RAd/p53 -- Radiation brachytherapy -- Radiation nurse -- Radiation physicist -- Radiation surgery -- Radical lymph node dissection -- Radioactive drug -- Radioactive palladium -- Radioactive seed -- Radioimmunoguided surgery -- Radiologic exam -- Radionuclide scanning -- Radiosensitizer -- Raftilose Synergy 1 -- Rapid hormone cycling -- Ras peptide -- Ravuconazole -- Rebeccamycin analog -- Recombinant adenovirus-p53 -- Recombinant fowlpox-CEA-MUC-1-TRICOM vaccine -- Recombinant fowlpox-TRICOM vaccine -- Recombinant tissue plasminogen activator -- Recombinant vaccinia-TRICOM vaccine -- Reconstructive surgeon -- Regional lymph node dissection -- Rehabilitation specialist -- Relative survival rate -- Remote brachytherapy -- Renal function test -- Renal glomerulus -- Resectoscope -- Retin-A-Micro -- Retrospective cohort study -- Retrospective study -- RFT5-dgA immunotoxin -- Rhabdoid tumor -- Rheumatrex -- Rhinoscope -- Ribonucleotide reductase inhibitor -- Richter syndrome -- Richter transformation -- Ro 31-7453 -- Ro 50-3821 -- Romidepsin -- Ropivacaine hydrochloride -- Rubex -- S-phase fraction -- S100 calcium binding protein A8 -- S100 calcium binding protein A9 -- Safingol -- Salivary gland cancer -- Samarium 153 -- Samarium Sm 153 lexidronam pentasodium -- SarCNU -- Sarcomatoid carcinoma -- Sarcosinamide nitrosourea -- Schiller test -- Scintimammography -- Sedoxantrone trihydrochloride -- Segmental resection -- Segmentectomy -- Seocalcitol -- Seromycin -- Sertoli-Leydig cell tumor of the ovary -- Serum tumor marker test -- Sestamibi breast imaging -- Severe myelosuppression -- Shave biopsy -- Sheridan’s Formula -- Sho-saiko-to -- Sialyl Tn-KLH -- Side-to-end coloanal anastomosis -- Sideropenic dysphagia -- Signal transduction inhibitor -- Signet ring cell carcinoma -- Silicon phthalocyanine 4 -- Single blind study -- Skin conduction -- Smoldering leukemia -- Smoldering myeloma -- SN-38 liposome -- Soblidotin -- Soliris -- Sorafenib tosylate -- Spiculated mass -- Spindle cell cancer -- Spindle cell sarcoma -- Spiral CT scan -- Spotted thistle -- Squalamine lactate -- St. Benedict's thistle -- Stage III multiple myeloma -- Stereotactic biopsy -- Stereotactic body radiation therapy -- Stereotactic external-beam radiation therapy -- Stereotactic injection -- Stereotactic radiation therapy -- Stereotactic radiosurgery -- Stereotaxic radiation therapy -- Stereotaxic radiosurgery -- Sterile talc powder -- Steroid cream -- Steroid drug -- Steroid metabolism gene -- Stromagen -- Stromal tumor -- Study agent -- Subcutaneous port -- Suction aspiration -- Suction evacuation -- Sun's Soup -- Supplemental nutrition -- Surface electrode -- Surgical oncologist -- Syngeneic bone marrow transplantation -- Syngeneic stem cell transplantation -- Synthetic protegrin analog -- Synthetic retinoid -- Systemic radiation therapy -- T-cell acute lymphocytic leukemia -- T-lymphoblastic lymphoma -- TAG-72 antigen -- Talabostat -- Talabostat mesylate -- Talampanel -- Talaporfin sodium -- Talotrexin -- Tandutinib -- Tariquidar -- Taurolidine -- Technetium Tc 94m sestamibi -- Technetium Tc 99m dextran -- Tegafur-uracil -- Telcyta -- Temsirolimus -- Tetanus toxoid -- Tetra-O-methyl NDGA -- Tetra-O-methyl nordihydroguaiaretic acid -- Tetrahydrouridine -- Theraloc -- Thoracic surgeon -- Thoracic surgical oncologist -- Thoracoscope -- Thrombohemorrhagic event -- Thymic carcinoma -- Thymidylate synthase inhibitor -- Thymitaq -- Thyrogen -- Thyroid follicular cell -- Tiacumicin B -- Time to progression -- Tin Sn 117m DTPA -- Tinzaparin sodium -- Tissue flap reconstruction -- TNF-bound colloidal gold -- TNFerade -- TNM staging system -- Tocladesine -- Topoisomerase II inhibitor RTA 744 -- Totect -- TP-38 immunotoxin -- Trabectedin -- Trabecular cancer -- Trach tube -- Tracheoesophageal puncture -- Tracheostomy button -- Tracheostomy tube -- Transabdominal ultrasound -- Transferrin-CRM107 -- Transperineal biopsy -- Transplant surgeon -- Transrectal biopsy -- Transsphenoidal surgery -- Transurethral biopsy -- Transurethral needle ablation -- Transurethral radiofrequency ablation -- Traumeel S -- Trelstar -- Treosulfan -- Triacetyluridine -- Tubefeeding -- Tubulovillous adenoma -- Tumor antigen vaccine -- Tumor board review -- Tumor infiltrating lymphocyte -- Tumor initiation -- Tumor promotion -- Tumor vasculature–targeted tumor necrosis factor alpha -- Tumor-specific antigen -- Type 3 serotonin receptor antagonist -- Type C thymoma -- Tyrosinase peptide -- Tyrosine kinase inhibitor BIBF 1120 -- Uftoral -- Ultrasound biomicroscopy -- Ultrasound energy -- Ultrasound transducer -- Ultrasound-guided biopsy -- Ultraviolet radiation therapy -- Uncontrolled study -- Urologic oncologist -- Vaccine adjuvant -- Vaccine therapy -- Vaccinia CEA vaccine -- Vaccinia-TRICOM vaccine -- Valerianae radix -- Vapreotide -- Varenicline tartrate -- Vascular endothelial growth factor-antisense oligonucleotide -- Vatalanib -- VEGF Trap -- Velafermin -- Venous sampling -- Villous adenoma -- Vinflunine -- Virulizin -- Viscotoxin -- Visual pathway glioma -- Vitamin A acid -- Wedge resection -- WGA study -- Whole genome association study -- Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome -- Wobe-Mugos E -- Xerogram -- Xeroradiograph -- Xeroradiography -- Xyotax -- Yttrium Y 90 DOTA monoclonal antibody HuPAM4 -- Yttrium Y 90 DOTA-biotin --